How different PrEP products can improve HIV prevention for young women in Kenya
Effectiveness of PrEP product choice on HIV prevention coverage among young women in Kenya seeking reproductive health services
This study is looking at how well different HIV prevention methods, like special rings and injections, work for young women in Kenya, and it aims to make it easier for them to use these options by improving support from healthcare providers.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10929488 on NIH RePORTER |
What this research studies
This research investigates the effectiveness of various PrEP products, such as dapivirine-eluting vaginal rings and intramuscular injections, in preventing HIV among young women in Kenya. It aims to understand how these longer-acting options can be integrated into existing reproductive health services to improve adherence and reduce dropout rates. By collaborating with public clinic staff, the study focuses on training providers and developing systems to support the delivery of PrEP. The goal is to enhance access to HIV prevention methods for young women who are at high risk.
Who could benefit from this research
Good fit: Ideal candidates for this research are young women aged 15-30 in Kenya who are at high risk for HIV and seeking reproductive health services.
Not a fit: Patients who are not at risk for HIV or those who do not seek reproductive health services may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase HIV prevention coverage among young women, leading to better health outcomes.
How similar studies have performed: Previous research has shown promise in integrating longer-acting PrEP products into reproductive health services, indicating potential for success in this approach.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Heffron, Renee a. — University of Alabama at Birmingham
- Study coordinator: Heffron, Renee a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.